Advisor Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 5213 |
|
|
2019
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 5213 |
|
|
2019
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 5198 |
|
|
2019
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 5182 |
|
|
2018
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 5074 |
|
|
2018
Q3 | $0 | Sell |
50
-200
| -80% | – | ﹤0.01% | 5082 |
|
|
2018
Q2 | $1K | Hold |
250
| – | – | ﹤0.01% | 4759 |
|
|
2018
Q1 | $1K | Sell |
250
-200
| -44% | -$800 | ﹤0.01% | 4779 |
|
|
2017
Q4 | $2K | Buy |
+450
| New | +$2K | ﹤0.01% | 4656 |
|
|
2017
Q1 | – | Sell |
-1,000
| Closed | -$6K | – | 4676 |
|
|
2016
Q4 | $6K | Sell |
1,000
-1,000
| -50% | -$6K | ﹤0.01% | 3825 |
|
|
2016
Q3 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 3599 |
|
|
2016
Q2 | $5K | Buy |
+2,000
| New | +$5K | ﹤0.01% | 3756 |
|